Zhu Yibin, Yu Xi, Cheng Gong
Tsinghua University-Peking University Joint Center for Life Sciences, School of Medicine Tsinghua University Beijing China.
Shenzhen Bay Laboratory Institute of Infectious Diseases Shenzhen China.
mLife. 2023 Jun 4;2(2):107-120. doi: 10.1002/mlf2.12064. eCollection 2023 Jun.
As the largest organ of the body, the skin acts as a barrier to prevent diseases and harbors a variety of beneficial bacteria. Furthermore, the skin bacterial microbiota plays a vital role in health and disease. Disruption of the barrier or an imbalance between symbionts and pathogens can lead to skin disorders or even systemic diseases. In this review, we first provide an overview of research on skin bacterial microbiota and human health, including the composition of skin bacteria in a healthy state, as well as skin bacterial microbiota educating the immune system and preventing the invasion of pathogens. We then discuss the diseases that result from skin microbial dysbiosis, including atopic dermatitis, common acne, chronic wounds, psoriasis, viral transmission, cutaneous lupus, cutaneous lymphoma, and hidradenitis suppurativa. Finally, we highlight the progress that utilizes skin microorganisms for disease therapeutics, such as bacteriotherapy and skin microbiome transplantation. A deeper knowledge of the interaction between human health and disease and the homeostasis of the skin bacterial microbiota will lead to new insights and strategies for exploiting skin bacteria as a novel therapeutic target.
作为人体最大的器官,皮肤起到屏障作用以预防疾病,并容纳多种有益细菌。此外,皮肤细菌微生物群在健康和疾病中起着至关重要的作用。屏障破坏或共生菌与病原体之间的失衡会导致皮肤疾病甚至全身性疾病。在本综述中,我们首先概述皮肤细菌微生物群与人类健康的研究,包括健康状态下皮肤细菌的组成,以及皮肤细菌微生物群对免疫系统的影响和对病原体入侵的预防作用。然后我们讨论由皮肤微生物失调导致的疾病,包括特应性皮炎、寻常痤疮、慢性伤口、银屑病、病毒传播、皮肤狼疮、皮肤淋巴瘤和化脓性汗腺炎。最后,我们强调利用皮肤微生物进行疾病治疗的进展,如细菌疗法和皮肤微生物群移植。对人类健康与疾病之间的相互作用以及皮肤细菌微生物群的稳态有更深入的了解,将为把皮肤细菌作为新型治疗靶点开发新的见解和策略。